13th DSANJ Digital Bio Conference 2024
Call for presentation (proposal) project

13th D-Bio Digital'24 Call for presentation proposal

The Japan Agency for Medical Research and Development (AMED), the Japan Pharmaceutical Manufacturers Association (JPMA), the Osaka Chamber of Commerce and Industry (OCCI) and the Institute for New Drug Combinations (INN) are inviting presentations (proposals) at the 13th DSANJ Digital Bio Conference 2024 (hereafter '13th D-Bio Digital The 13th DSANJ Digital Bio Conference 2024 (hereafter referred to as '13th D-Bio Digital '24') is an opportunity to partner with pharmaceutical companies.

At the 13th D-Bio Digital'24, you can use the web-based interview system (Zoom Meeting is planned) to meet with pharmaceutical companies (40 minutes per company on an individual basis) for partnering (e.g. joint research). In addition, as in previous years, research results presented (proposals) will automatically become candidates for support by the AMED Drug Discovery Boosters (*Note 1).

Due to the web interview system, 60 slots are scheduled for presentations. The presentations will be selected in the order of the research results with the highest number of requests for interviews from participating companies.

The application period is from Friday 8 December to Monday 18 December.

This is a valuable opportunity to collaborate with pharmaceutical companies (*Note 2) and to obtain support from the AMED Drug Discovery Boosters. We look forward to your participation in the 13th D-Bio Digital'24 in order to accelerate the implementation of your research results in society.

(*Note 1) The research results that attracted the most requests for support from pharmaceutical companies at the 13th D-Bio Digital'24 are eligible.
(*Note 2) Around 40 companies are expected to participate.

Overview of the event

Date and time Thursday 25, Friday 26, Monday 29, Tuesday 30 and Wednesday 31 January 2024, 10:00 - 18:00
Organisers Japan Agency for Medical Research and Development (AMED), Japan Pharmaceutical Manufacturers Association, Osaka Chamber of Commerce and Industry.
Organised by.
DSANJ Business Supervisory Body
General Institute for New Combinations in Medicine
Management Secretariat Inter Group Corporation
Co-organised by Osaka Prefecture and Kansai Pharmaceutical Association.
Supported by Osaka City
Place You can use the web-based interview system (Zoom Meeting is planned) to participate from a convenient location such as the teacher's laboratory, a conference room or your own home.
*You will have the opportunity to check in advance that you can connect to the web interview system at the location you will attend on the day.
Participants About 60 presenters (researchers from universities and other research institutions, start-ups, etc.) who hold research results related to drug discovery.
Around 40 pharmaceutical companies
Participation is free of charge (no contingency fees or other costs will be incurred in the event of collaboration with participating pharmaceutical companies, such as joint research).

Click below to find out more.

Application outline

Application process

1.Please do not include confidential information in your presentation (proposal) material (Form 3). The Organising Organisation and the Steering Secretariat will not handle any confidential information at the 13th D-Bio Digital'24.

2.Please limit one presentation (proposal) per researcher to one theme. If you wish to present (or propose) more than one theme, we kindly ask you to nominate a co-researcher or another person from the same research group.

3.AMED invitation slots are available for researchers who have won AMED research funding. For further details, please refer to the information provided by the AMED Practical Application Promotion and Intellectual Property Support Section.

Registration period Friday 8 December - Monday 18 December 2024,noon
*If there is a possibility that the application may not be submitted in time due to coordination with co-researchers, etc,
Please contact the Management Secretariat (see below) in advance.
Subjects.
Your research results

Research results being researched and developed in Japan.
Research results supported by the AMED.
Your research results related to APAC led by the Japan Pharmaceutical Manufacturers Association (JPMA).
*We actively welcome applications from start-ups and biotechs.

theme

Drug discovery seeds, drug discovery platform technologies, biomarkers, diagnostics and diagnostic technologies, digital therapeutics (e.g. apps), medical devices intended for use in combination with therapeutic agents, etc. (excluding medical devices used alone) that apply to any disease.
Metabolic diseases, cardiovascular diseases, bone and joint disease areas, infectious disease areas, respiratory disease areas, cancer and malignant neoplasms, central nervous system diseases, pain, ophthalmic diseases, immunology, inflammation, allergic diseases, skin diseases, gastrointestinal, urological diseases, gynaecological diseases and rare diseases.

How to apply for participation

From this year, the registration has been changed to a web-based registration. Please access the following page to register your participation.

Participation documents

Click on the blue buttons to download the relevant documents.
*Form 2, Form 3 and Form 4 will be uploaded by Monday 20 November.
*Please make sure to use the 13th form when applying for participation.

Confirmation of participation (Form 2)

Presentation (proposal) material (Form 3)

Business card information (Form 4)

Notes on the preparation of presentation (proposal) materials
Preparing your presentation (proposal) material in accordance with the guidelines will help attract the interest of pharmaceutical companies.
Due to the uploading and downloading of data, we ask that you resize the images to a size of around 20M (if the size is large, the Management Office may carry out the resizing process).

*Please see below for examples of how to prepare proposal documents.

Even if you are not invited, your presentation (proposal) materials will be disclosed to the companies participating in the 13th D-Bio Digital'24.

How to apply for participation

Please follow the steps below to apply for participation.

Step 1.

Access the dedicated webpage for registration, fill in the required information and click on the registration button.

Step two.

The Steering Secretariat will issue you with a D-Bio system ID and password, and you can log in to the system.

Step three.

Upload the confirmation of participation (Form 2), your presentation (proposal) materials (Form 3) and business card information (Form 4) to the D-Bio system.

Invitation notification We will contact you via the D-Bio system in the last week of December to inform you of the number of companies we wish to interview.

contact information (for enquiries)

Organisation 13th DSANJ Digital Bio Conference 2024 Management Secretariat
(Inter Group Corporation)
Contact person Kambe, Yonezawa
Address 20-1, Toyosaki 3-chome, Kita-ku, Osaka 531-0072, Japan
E-mail info@dbio.jp
Tel Dedicated DSANJ telephone number [050-5490-4115].
*If the above IP phones cannot be connected,
Please call the Convention Department [06-6372-8455] of Intergroup Ltd.
*Phone calls are answered between 10am and 5pm.
Outside these hours, please contact us by email ❬ info@dbio.jp ❭.